Bibliography
- ZHANG WW, FUJIWARA T, GRIMM EA, ROTH JA: Advances in cancer gene therapy. Adv. Pharmacol. (1995) 12:289–341.
- BRIDGEWATER G, SPRINGER CJ, KNOX R, MINTON N, COLLINS M: Expression of the bacterial nitroreductase enzyme in mammalian cell renders them selectively sensitive to killing by the prodrug CB-1954. Eur. J. Cancer (1995) 31A:2362–2370.
- MARAIS R, SPOONER RA, LIGHT Y, MARTIN J, SPRINGER CJ: Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination. Cancer Res. (1996) 56:4735–4742.
- HUBER BE, RICHARDS CA, AUSTIN EA: An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancer. Adv. Drug Delivery Rev. (1995) 17:279–292.
- HUBER BE, AUSTIN EA, RICHARDS SE, DAVIS ST, GOOD SS: Metabolism of 5-fluorocytidine to 5-fluorouracil in human colorectal tumor cells transduced with cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA (1994) 91:8302–8306.
- NICULESCU-DUVAZ I, SPRINGER CJ: Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinations. Exp. Opin. Invest. Drugs (1997) 6(6):685–703.
- DENNY WA, WILSON WR: The design of selectively-activated anti-cancer prodrugs for use in antibody-directed enzyme prodrug therapy and gene-directed enzyme prodrug therapy. J. Pharm. Pharmacol (1998) 50:387–394.
- ZHANG WW: Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther. (1999) 6:113–138.
- LATTIME EC, GERSON SL: Gene therapy of cancer. In: Translational Approaches from Preclinical Studies to Clinical Implementation. Academic Press, New York, USA (1999).
- NICULESCU-DUVAZ I, SPOONER R, MARAIS R, SPRINGER CJ: Gene-directed enzyme prodrug therapy. Bioconj Chem. (1998) 9:4–22.
- NICULESCU-DUVAZ I, COOPER RG, STRIBBLING S, HEYES JA, METCALFE JA, SPRINGER CJ: Recent developments in GDEPT for cancer. Curr. Opin. MM. Ther. (1999) 1:480–486.
- PAVLOVIC J, NAWRAT M, TU R, HEINICKE T, MOELLING K: Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras (G12V). Gene Ther. (1996) 3:635–643.
- CHEN SH, KOSAI K, XU B et al.: Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res. (1996) 56:3758–3762.